RSV protection rises with vaccine for older people and new infants

To supplement respiratory syncytial (RSV) virus vaccines, from September 2025, the NHS will offer monoclonal antibody nirsevimab to protect around 7,000 premature or high-risk babies and infants during their first RSV season.…
Published: 4 August 2025